Skip to main navigation
Fate Therapeutics
0
Primary Menu
Skip to content
About Us
Our Mission
Our Cells of Interest
Management
Board of Directors
Corporate Responsibility
Pipeline
Overview
Product Candidates
FT576
FT522
FT819
FT825
Expanded Access Policy
Science
iPSC Platform
Manufacturing
Publications
Collaborations
Working at Fate
The Fate Way
Join our Team
Investors
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Annual Reports and Proxies
Corporate Governance
Stock Information
Historic Stock Lookup
Investors FAQs
Contact
Investors
Overview
Press Releases
Events & Presentations
Financial & Filings
Corporate Governance
Stock Information
Investors FAQs
Fate 1Q 2023 Earnings
May
03
2023
May 3, 2023 at 5:00 PM EDT
May 3, 2023
5:00 PM EDT
Listen To Webcast